Eli Lilly & Company vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.: FDA Enforcement Comparison

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. has been the subject of 199 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Eli Lilly & Company.

Eli Lilly & Company: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.: 0 warning letters, 199 recalls, 0 approval records, 0 Form 483s.

Side by side

Eli Lilly & Company — Warning letters0

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. — Warning letters0

Eli Lilly & Company — Recalls1

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. — Recalls199

Eli Lilly & Company — Approval records0

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. — Approval records0

Eli Lilly & Company — Form 483s0

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. — Form 483s0

Timeline

Eli Lilly & Company

Most recent FDA action: April 24, 2024

Full history →

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.

Most recent FDA action: June 24, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Eli Lilly & Company vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.: FDA Enforcement Comparison." Argus HQ, accessed July 17, 2026. https://argushq.ai/compare/eli-lilly-and-company-vs-philips-medical-systems-nederland-b-v

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗